Featured FARA News and Blogs

Reata Pharmaceuticals Announces
FDA Approval of SKYCLARYS™ (Omaveloxolone)

View the recently updated
Clinical Management Guidelines for Friedreich Ataxia

Available Now! FARA’s Annual Donor Impact Report

Biogen Acquires Reata Pharmaceuticals - An Update for the FA Community

Clinical Trials now Enrolling Volunteers Needed!

Activities & Events